omniture
logo
Search
I-MAB Biopharma Co., Ltd.
Media Room

Latest News

rss

First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors

SHANGHAI and ROCKVILLE, Md., May 13, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical stage bi...

2020-05-13 20:00 5350

I-Mab Biopharma Announces Dosing of First Patient in a Pivotal Study of TJ202/MOR202 in Multiple Myeloma in Mainland China

SHANGHAI, Jan. 3, 2020 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a global biopharmaceutical compan...

2020-01-04 00:07 1950
1 ... 45678